Acute Coronary Syndrome Associated with Carfilzomib Treatment.
作者信息
Kocabaş Umut, Atalay Figen, Altay Hakan, Altun Armağan, Pehlivanoğlu Seçkin
机构信息
Department of Cardiology, Başkent University Istanbul Hospital, Istanbul, Turkey.
Department of Hematology, Başkent University Istanbul Hospital, Istanbul, Turkey.
出版信息
Indian J Hematol Blood Transfus. 2020 Jul;36(3):592-593. doi: 10.1007/s12288-019-01237-z. Epub 2019 Dec 13.
Abstract
摘要
相似文献
1
Acute Coronary Syndrome Associated with Carfilzomib Treatment.与卡非佐米治疗相关的急性冠状动脉综合征
Indian J Hematol Blood Transfus. 2020 Jul;36(3):592-593. doi: 10.1007/s12288-019-01237-z. Epub 2019 Dec 13.
2
Proteasome Inhibition by Carfilzomib Induced Apotosis and Autophagy in a T-cell Acute Lymphoblastic Leukemia Cell Line.卡非佐米抑制蛋白酶体诱导T细胞急性淋巴细胞白血病细胞系凋亡和自噬
Iran J Pharm Res. 2019 Fall;18(Suppl1):132-145. doi: 10.22037/ijpr.2020.112692.13898.
3
Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy.心血管器官损伤和血压水平可预测接受卡非佐米治疗的多发性骨髓瘤患者的不良事件。
Cancers (Basel). 2019 May 3;11(5):622. doi: 10.3390/cancers11050622.
4
Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study.每周一次与每周两次卡非佐米给药治疗复发和难治性多发性骨髓瘤患者（A.R.R.O.W.）：一项随机、3 期研究的中期分析结果。
Lancet Oncol. 2018 Jul;19(7):953-964. doi: 10.1016/S1470-2045(18)30354-1. Epub 2018 Jun 1.
5
Fatal pulmonary toxicity due to carfilzomib (Kyprolis™).卡非佐米（凯普拉生™）所致的致命性肺毒性。
J Oncol Pharm Pract. 2016 Oct;22(5):720-4. doi: 10.1177/1078155215588630. Epub 2015 Jun 4.
6
Carfilzomib-associated tumor lysis syndrome.卡非佐米相关的肿瘤溶解综合征。
Pharmacotherapy. 2014 May;34(5):e34-7. doi: 10.1002/phar.1397. Epub 2014 Jan 4.
7
Pilot Study: Quantitative Photoacoustic Evaluation of Peripheral Vascular Dynamics Induced by Carfilzomib In Vivo.初步研究：体内用卡非佐米诱导的周围血管动力学的定量光声评估。
Sensors (Basel). 2021 Jan 27;21(3):836. doi: 10.3390/s21030836.
8
A case of acute liver failure due to carfilzomib in multiple myeloma.一例因卡非佐米导致的多发性骨髓瘤急性肝衰竭病例。
J Clin Pharm Ther. 2018 Dec;43(6):918-920. doi: 10.1111/jcpt.12741. Epub 2018 Jul 3.
9
Apremilast ameliorates carfilzomib-induced pulmonary inflammation and vascular injuries.阿普米司特可改善卡非佐米引起的肺部炎症和血管损伤。
Int Immunopharmacol. 2019 Jan;66:260-266. doi: 10.1016/j.intimp.2018.11.023. Epub 2018 Nov 28.
10
Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trials.卡非佐米治疗多发性骨髓瘤致肾毒性的风险：一项随机对照试验的荟萃分析。
Ann Hematol. 2020 Jun;99(6):1265-1271. doi: 10.1007/s00277-020-04062-x. Epub 2020 May 7.
引用本文的文献
1
Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib.研究不可逆蛋白酶体抑制剂卡非佐米的血管毒性结局。
Int J Mol Sci. 2020 Jul 22;21(15):5185. doi: 10.3390/ijms21155185.
Zotero 插件